Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle S Smith

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Nature|September 21, 2022
Unified rhombic lip origins of group 3 and group 4 medulloblastomaKyle S Smith, Laure Bihannic, Brian L Gudenas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2021
Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk MedulloblastomaJeff M Michalski, Anna J Janss, L Gilbert Vezina, et al.
Nature Cancer|February 17, 2026
M-PACT leverages cell-free DNA methylomes to achieve robust classification of pediatric brain tumorsKyle S Smith, Tom T Fischer, Katie Han, et al.
Cancer Cell|October 22, 2021
Serial assessment of measurable residual disease in medulloblastoma liquid biopsiesAnthony P Y Liu, Kyle S Smith, Rahul Kumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2021
Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)Amar Gajjar, Giles W Robinson, Kyle S Smith, et al.
The Lancet. Oncology|May 21, 2018
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trialGiles W Robinson, Vasilisa A Rudneva, Ivo Buchhalter, et al.
Cancer Cell|May 16, 2025
Isocitrate dehydrogenase 1 primes group-3 medulloblastomas for cuproptosisDerek Dang, Akash Deogharkar, John McKolay, et al.
Nature|July 26, 2019
Resolving medulloblastoma cellular architecture by single-cell genomicsVolker Hovestadt, Kyle S Smith, Laure Bihannic, et al.
Acta Neuropathologica|August 19, 2021
Subgroup and subtype-specific outcomes in adult medulloblastomaHallie Coltin, Lakshmikirupa Sundaresan, Kyle S Smith, et al.
Nature|April 17, 2020
Germline Elongator mutations in Sonic Hedgehog medulloblastomaSebastian M Waszak, Giles W Robinson, Brian L Gudenas, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Nature|September 21, 2022
Unified rhombic lip origins of group 3 and group 4 medulloblastomaKyle S Smith, Laure Bihannic, Brian L Gudenas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2021
Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk MedulloblastomaJeff M Michalski, Anna J Janss, L Gilbert Vezina, et al.
Nature Cancer|February 17, 2026
M-PACT leverages cell-free DNA methylomes to achieve robust classification of pediatric brain tumorsKyle S Smith, Tom T Fischer, Katie Han, et al.
Cancer Cell|October 22, 2021
Serial assessment of measurable residual disease in medulloblastoma liquid biopsiesAnthony P Y Liu, Kyle S Smith, Rahul Kumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2021
Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)Amar Gajjar, Giles W Robinson, Kyle S Smith, et al.
The Lancet. Oncology|May 21, 2018
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trialGiles W Robinson, Vasilisa A Rudneva, Ivo Buchhalter, et al.
Cancer Cell|May 16, 2025
Isocitrate dehydrogenase 1 primes group-3 medulloblastomas for cuproptosisDerek Dang, Akash Deogharkar, John McKolay, et al.
Nature|July 26, 2019
Resolving medulloblastoma cellular architecture by single-cell genomicsVolker Hovestadt, Kyle S Smith, Laure Bihannic, et al.
Acta Neuropathologica|August 19, 2021
Subgroup and subtype-specific outcomes in adult medulloblastomaHallie Coltin, Lakshmikirupa Sundaresan, Kyle S Smith, et al.
Nature|April 17, 2020
Germline Elongator mutations in Sonic Hedgehog medulloblastomaSebastian M Waszak, Giles W Robinson, Brian L Gudenas, et al.
Pageof 8